CD248 and idiopathic pulmonary fibrosis: Bartis et al. and Benedetto et al. demonstrated that the reduction of CD248 expression on the fibroblast cell line via siRNA resulted in the reduction of in vitro cell proliferation [23, 26], suggesting that CD248highITGA8low human fibroblast-like cells are possible candidates as therapeutic targets for IPF lungs.